Showing results (361-370 of 1,757) with videos related to
Sort By:
Pageof 176
Vascular Pharmacology|February 5, 2022
Perivascular adipose-derived exosomes reduce macrophage foam cell formation through miR-382-5p and the BMP4-PPARγ-ABCA1/ABCG1 pathwaysYan Liu, Yan Sun, Xuze Lin, et al.Vascular Pharmacology|June 14, 2014
PCSK9 inhibition for the treatment of hypercholesterolemia: promises and emerging challengesGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi CatapanoVascular Pharmacology|October 3, 2012
Gleditsioside B, a triterpene saponin isolated from the anomalous fruits of Gleditsia sinensis Lam., abrogates bFGF-induced endothelial cell migration through preventing the activation of MMP-2 and FAK via inhibiting ERK and PI3K/AKT signaling pathwaysBei Tong, Dan Lu, Zhifeng Wei, et al.Vascular Pharmacology|September 19, 2012
Effects of the radiocontrast agent iodixanol on endothelial cell morphology and functionNicoletta Ronda, Francesco Potì, Alessandra Palmisano, et al.Vascular Pharmacology|September 18, 2012
Rho GTPases in pulmonary vascular dysfunctionElisabeth M Storck, Beata Wojciak-StothardVascular Pharmacology|September 18, 2012
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertensionChien-nien Chen, Geoffrey Watson, Lan ZhaoVascular Pharmacology|June 19, 2012
Selective glycolysis blockade in guinea pig pulmonary artery and aorta reverses contractile and electrical responses to acute hypoxiaAnatoly I Soloviev, Alexander I Bondarenko, Igor V KizubVascular Pharmacology|July 24, 2012
The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanismsMin Shen, Lei Zhao, Rui-xin Wu, et al.Vascular Pharmacology|July 17, 2012
Alcohol and cardiovascular disease: still unresolved underlying mechanismsRoberto Carnevale, Cristina NocellaVascular Pharmacology|July 17, 2012
Oxidant stress and skeletal muscle microvasculopathy in the metabolic syndromeAdam G Goodwill, Jefferson C FrisbeePageof 176